Introduction {#sec1}
============

Nucleation is the initial process for the formation of crystals in solutions. In classical nucleation theory (CNT),^[@ref1]−[@ref3]^ the nucleation rate is expressed in the thermally activated Arrhenius form governed by the pre-exponential nucleation factor and interfacial energy. The interfacial energy is the energy required to create a new solid liquid interface for the formation of crystals in solutions. Traditionally, the interfacial energy is determined from the induction time measurements by assuming *J* ∝ *t*~i~^--1^.^[@ref1],[@ref4]−[@ref7]^ Generally, the higher the value of interfacial energy, the more difficult it is for the solute to crystallize.

As the nucleation behavior of the same solute is greatly influenced by the choice of solvent, the study of nucleation in various solvents has long been an important research subject.^[@ref8]−[@ref14]^ Recent studies have indicated an increasing trend of the interfacial energy with the increasing corresponding solute--solvent interaction for the same solute in various solvents.^[@ref15]−[@ref18]^ Apart from the interfacial energy, nucleation should also be influenced by the pre-exponential factor based on CNT. However, few studies have been published regarding to the influence of the solvent type on the pre-exponential factor for nucleation.

Although the pre-exponential factor is related to the solute mobility in solutions, it is also implicitly dependent on the interfacial energy of a crystalline solid according to the derivation of CNT,^[@ref2],[@ref3],[@ref19]^ which nevertheless has not been experimentally validated in the literature. Nucleation in various solvents for a system can provide important information for nucleation rate parameters. In this work, the influence of the solvent type on nucleation will be investigated based on CNT to examine the implicit relationship between the pre-exponential factor and interfacial energy in various solvents using the induction time data for three common model compounds widely studied in crystal engineering, including isonicotinamide, lovastatin, and phenacetin. The chemical structures of these compounds are given in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}. Various common crystal structures of these compounds have been reported in the literature.^[@ref20]−[@ref23]^

![Chemical structures of (a) isonicotinamide, (b) lovastatin, and (c) phenacetin.](ao9b02102_0001){#fig1}

Theory {#sec2}
======

The nucleation rate based on CNT is expressed as^[@ref1]−[@ref3]^where *A*~J~ is the nucleation pre-exponential factor, γ is the interfacial energy, *k*~B~ is the Boltzmann constant, is the molecular volume, and *S* = *C*~0~/*C*~eq~ is the supersaturation ratio. As the solute attachment for small critical nucleus in a stirred solution should be interface-transfer control, it yields based on CNT^[@ref2],[@ref3],[@ref19]^where *D*~AB~ is the solute diffusivity in the solution.

For simplicity, the solute diffusivity is usually estimated based on the Stokes--Einstein equation as^[@ref1]^where *r*~0~ is the molecular radius of solute and η is the solution viscosity. As *D*~AB~ is generally assumed to be proportional to *T*/η(*T*,*S*) for the same solute among various solvents,^[@ref10],[@ref13],[@ref19]^[eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"} becomes

To differentiate between the effects of γ^1/2^ and *T*/η(*T*,*S*) on *A*~J~, the intrinsic nucleation factor *A*~0~ is introduced in this work as^[@ref24]^

Substituting [eq [5](#eq5){ref-type="disp-formula"}](#eq5){ref-type="disp-formula"} into [eq [4](#eq4){ref-type="disp-formula"}](#eq4){ref-type="disp-formula"} yields

Consequently, although *A*~J~ in [eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"} is dependent on *D*~AB~ among various solvents, *A*~0~ is not related to the dependence of *D*~AB~ on *T*/η(*T*,*S*) among various solvents. Substituting [eq [5](#eq5){ref-type="disp-formula"}](#eq5){ref-type="disp-formula"} into [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"} yields

Thus, *J* is expressed in terms of *A*~0~ and γ, as opposed to *J* commonly adopted in terms of *A*~J~ and γ in [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}.

In the induction time study, the nucleation event is usually assumed to correspond to a point at which the total number density of accumulated crystals in a vessel has reached a fixed (but unknown) value, *f*~*N*~.^[@ref25]−[@ref28]^ Thus, one obtains at the nucleation time *t*~i~where *f*~*N*~ depends on the measurement device and on the substance. Note that [eq [8](#eq8){ref-type="disp-formula"}](#eq8){ref-type="disp-formula"} is consistent with *J* ∝ *t*~i~^--1^ reported in the literature.^[@ref1]^ Based on the study of 28 systems, Mersmann and Bartosch^[@ref29]^ estimated *f*~V~ = 10^--4^ to 10^--3^ with a detectable size of 10 μm. If the intermediate value, *f*~V~ = 4 × 10^--4^, for spherical nuclei with *k*~V~ = π/6 is assumed, it leads to *f*~*N*~ = 7.64 × 10^11^ m^--3^ proposed by Shiau.^[@ref24]^

Substituting [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"} into [eq [8](#eq8){ref-type="disp-formula"}](#eq8){ref-type="disp-formula"} yields

Experimental induction time data can be evaluated by plotting ln(1/*t*~i~) versus 1/*T*^3^ ln^2^*S* for determination of γ from the slope and *A*~J~ from the intercept, respectively.

Substituting [eq [7](#eq7){ref-type="disp-formula"}](#eq7){ref-type="disp-formula"} into [eq [8](#eq8){ref-type="disp-formula"}](#eq8){ref-type="disp-formula"} yields

Experimental induction time data can be evaluated by plotting ln\[η(*T*,*S*)/*t*~i~*T*\] versus 1/*T*^3^ ln^2^*S* for determination of γ from the slope and *A*~0~ from the intercept, respectively.

Results and Discussion {#sec3}
======================

[Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}--[3](#tbl3){ref-type="other"} list the experimental average induction time data of each solute in various solvents measured for various *S* at the specified temperature for three crystallization systems, including isonicotinamide, lovastatin, and phenacetin. The induction time measurements under each condition are repeated three times, and the deviation of the induction time is generally less than 15%. In the following, [eqs [9](#eq9){ref-type="disp-formula"}](#eq9){ref-type="disp-formula"} and [10](#eq10){ref-type="disp-formula"} are applied to determine the nucleation kinetics in various solvents using the induction time data for each system.

###### Experimental Induction Time Data of Isonicotinamide in Each Solvent for Various *S* at 303 K

  solute            solvent         *S* (-)   *t*~i~ (s)
  ----------------- --------------- --------- ------------
  isonicotinamide   methanol        1.43      664
                                    1.45      564
                                    1.50      400
                                    1.55      370
                    acetone         1.20      1077
                                    1.25      330
                                    1.30      186
                                    1.40      122
                    acetonitrile    1.10      2879
                                    1.13      1338
                                    1.14      787
                                    1.20      206
                    ethyl acetate   1.05      1156
                                    1.07      605
                                    1.10      589
                                    1.15      341

###### Experimental Induction Time Data of Lovastatin in Each Solvent for Various *S* at 303 K

  solute       solvent         *S* (-)   *t*~i~ (s)
  ------------ --------------- --------- ------------
  lovastatin   ethyl acetate   1.45      1139
                               1.50      970
                               1.60      573
                               1.70      275
               ethanol         1.40      1998
                               1.50      1240
                               1.70      633
                               1.90      357
               butyl acetate   1.40      1156
                               1.45      788
                               1.50      531
                               1.70      363
               methanol        1.30      1389
                               1.40      889
                               1.50      378
                               1.70      278
               acetone         1.25      846
                               1.30      545
                               1.40      447
                               1.50      321

###### Experimental Induction Time Data of Phenacetin in Each Solvent for Various *S* at 298 K

  solute       solvent         *S* (-)   *t*~i~ (s)
  ------------ --------------- --------- ------------
  phenacetin   ethanol         1.10      3507
                               1.15      1223
                               1.18      638
                               1.20      530
               acetonitrile    1.04      3602
                               1.07      842
                               1.10      377
                               1.113     279
               ethyl acetate   1.05      1799
                               1.07      1114
                               1.09      737
                               1.12      504

In the application of [eq [10](#eq10){ref-type="disp-formula"}](#eq10){ref-type="disp-formula"}, the solution viscosities η(*T*,*S*) in various solvents for each system are experimentally measured in this work using a rotational viscometer (Brookfield DV2T). The measurements under each condition are repeated three times, and the deviation of the viscosity value is generally less than 6%.

[Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a shows the measured supersaturation dependence of solution viscosity for isonicotinamide in various solvents at 303 K, where *C*~eq~ for isonicotinamide in each solvent at 303 K is taken from a report by Hansen et al.^[@ref22]^ (*C*~eq~ = 210 mg solute/g solvent for methanol, *C*~eq~ = 11 mg solute/g solvent for ethyl acetate, *C*~eq~ = 23 mg solute/g solvent for acetonitrile, and *C*~eq~ = 37 mg solute/g solvent for acetone). [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b shows the measured induction time data fitted to [eq [10](#eq10){ref-type="disp-formula"}](#eq10){ref-type="disp-formula"} for isonicotinamide in various solvents at 303 K, where the induction time data are experimentally obtained in this work for various initial concentrations cooled to 303 K. [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}c shows that *A*~0~ increases linearly with increasing γ^1/2^ for isonicotinamide in various solvents at 303 K, where *A*~0~ and γ in each solvent are determined using the corresponding induction time data fitted to [eq [10](#eq10){ref-type="disp-formula"}](#eq10){ref-type="disp-formula"}. On the other hand, [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}d shows that no clear relationship is observed between *A*~J~ and γ^1/2^ for isonicotinamide in various solvents at 303 K, where *A*~J~ and γ in each solvent are determined using the corresponding induction time data fitted to [eq [9](#eq9){ref-type="disp-formula"}](#eq9){ref-type="disp-formula"}.

![Isonicotinamide in various solvents: (a) dependence of η on supersaturation at 303 K; (b) induction time data fitted to [eq [10](#eq10){ref-type="disp-formula"}](#eq10){ref-type="disp-formula"} at 303 K; (c) linear relationship between *A*~0~ and γ^1/2^ at 303 K; and (d) *A*~J~ vs γ^1/2^ at 303 K.](ao9b02102_0002){#fig2}

As shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a, η increases in the order: acetone \< acetonitrile \< ethyl acetate \< methanol. Although [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}c shows that *A*~0~ increases in the order: ethyl acetate \< acetonitrile \< acetone \< methanol, *A*~J~ in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}d increases in the order: ethyl acetate \< methanol \< acetonitrile \< acetone, which is different from the increasing order of *A*~0~. It should be noted that η in methanol is significantly greater than that in other solvents. Consequently, although *A*~0~ in methanol is the greatest among various solvents, *A*~J~ in methanol becomes smaller than that in acetone or acetonitrile because of [eq [5](#eq5){ref-type="disp-formula"}](#eq5){ref-type="disp-formula"}.

[Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a shows the measured supersaturation dependence of solution viscosity for lovastatin in various solvents at 303 K, where *C*~eq~ for lovastatin in each solvent at 303 K is taken from a report by Sun et al.^[@ref30]^ (*C*~eq~ = 38 mg solute/g solvent for ethanol, *C*~eq~ = 22 mg solute/g solvent for butyl acetate, *C*~eq~ = 52 mg solute/g solvent for methanol, *C*~eq~ = 31 mg solute/g solvent for ethyl acetate, and *C*~eq~ = 105 mg solute/g solvent for acetone). [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}b shows the measured induction time data fitted to [eq [10](#eq10){ref-type="disp-formula"}](#eq10){ref-type="disp-formula"} for lovastatin in various solvents at 303 K, where the induction time data are experimentally obtained in this work for various initial concentrations cooled to 303 K. [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}c shows that *A*~0~ increases linearly with increasing γ^1/2^ for lovastatin in various solvents at 303 K, where *A*~0~ and γ in each solvent are determined using the corresponding induction time data fitted to [eq [10](#eq10){ref-type="disp-formula"}](#eq10){ref-type="disp-formula"}. On the other hand, [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}d shows that no clear relationship is observed between *A*~J~ and γ^1/2^ for lovastatin in various solvents at 303 K, where *A*~J~ and γ in each solvent are determined using the corresponding induction time data fitted to [eq [9](#eq9){ref-type="disp-formula"}](#eq9){ref-type="disp-formula"}.

![Lovastatin in various solvents: (a) dependence of η on supersaturation at 303 K; (b) induction time data fitted to [eq [10](#eq10){ref-type="disp-formula"}](#eq10){ref-type="disp-formula"} at 303 K; (c) linear relationship between *A*~0~ and γ^1/2^ at 303 K; and (d) *A*~J~ vs γ^1/2^ at 303 K.](ao9b02102_0003){#fig3}

[Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}a shows the measured supersaturation dependence of solution viscosity for phenacetin in various solvents at 298 K, where *C*~eq~ for phenacetin in each solvent at 298 K is taken from a report by Croker et al.^[@ref21]^ (*C*~eq~ = 72 mg solute/g solvent for ethanol, *C*~eq~ = 24 mg solute/g solvent for ethyl acetate, and *C*~eq~ = 48 mg solute/g solvent for acetonitrile). [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b shows the measured induction time data fitted to [eq [10](#eq10){ref-type="disp-formula"}](#eq10){ref-type="disp-formula"} for phenacetin in various solvents at 298 K, where the induction time data are experimentally obtained in this work for various initial concentrations cooled to 298 K. [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}c shows that *A*~0~ increases linearly with increasing γ^1/2^ for phenacetin in various solvents at 298 K, where *A*~0~ and γ in each solvent are determined using the corresponding induction time data fitted to [eq [10](#eq10){ref-type="disp-formula"}](#eq10){ref-type="disp-formula"}. On the other hand, [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}d shows that no clear relationship is observed between *A*~J~ and γ^1/2^ for phenacetin in various solvents at 298 K, where *A*~J~ and γ in each solvent are determined using the corresponding induction time data fitted to [eq [9](#eq9){ref-type="disp-formula"}](#eq9){ref-type="disp-formula"}.

![Phenacetin in various solvents: (a) dependence of η on supersaturation at 298 K; (b) induction time data fitted to [eq [10](#eq10){ref-type="disp-formula"}](#eq10){ref-type="disp-formula"} at 298 K; (c) linear relationship between *A*~0~ and γ^1/2^ at 298 K; and (d) *A*~J~ vs γ^1/2^ at 298 K.](ao9b02102_0004){#fig4}

As shown in [Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a,[3](#fig3){ref-type="fig"}a, and [4](#fig4){ref-type="fig"}a, the supersaturation dependence of solution viscosity in these systems is nearly negligible because of the narrow concentration range associated with the varied supersaturations. [Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"} lists the value of γ and the correlation coefficient *R*^2^ for each line in [Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b, [3](#fig3){ref-type="fig"}b, and [4](#fig4){ref-type="fig"}b. The value of γ in each solvent for these systems agrees with the reported literature value.^[@ref27],[@ref28]^ Note that the correlation coefficient in each solvent for these systems exceeds the critical value of 0.900 for the 90% confidence interval and 4 points (i.e., degree of freedom = 2).

###### Value of γ and the Correlation Coefficient for Each Line in [Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b, [3](#fig3){ref-type="fig"}b, and [4](#fig4){ref-type="fig"}b

  solute            solvent         γ (mJ/m^2^)   *R*^2^ (-)
  ----------------- --------------- ------------- ------------
  isonicotinamide   methanol        3.32          0.973
                    acetone         2.53          0.992
                    acetonitrile    1.72          0.951
                    ethyl acetate   0.77          0.900
  lovastatin        ethyl acetate   1.94          0.915
                    ethanol         1.72          0.959
                    butyl acetate   1.62          0.974
                    methanol        1.44          0.926
                    acetone         1.08          0.965
  phenacetin        ethanol         1.17          0.964
                    acetonitrile    0.674         0.960
                    ethyl acetate   0.632         0.943

[Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"} lists comparison between the correlation coefficient for each line in [Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}c, [3](#fig3){ref-type="fig"}c, and [4](#fig4){ref-type="fig"}c and the corresponding critical value based on the 95% confidence interval. As the correlation coefficient for these systems exceeds the corresponding critical value based on the 95% confidence interval, it is concluded that *A*~0~ increases linearly with increasing γ^1/2^ in various solvents for each system. As an increasing trend of the interfacial energy with the increasing corresponding solute--solvent interaction for the same solute in various solvents has been reported in the literature,^[@ref15]−[@ref18]^ it is speculated that the effect of this interaction on γ is also strongly correlated with that on *A*~0~ for the same system. Consequently, if the choice of solvent results in a greater γ because of a stronger solute--solvent interaction, it simultaneously results in a greater *A*~0~. On the other hand, if the choice of solvent results in a smaller γ because of a weaker solute--solvent interaction, it simultaneously results in a smaller *A*~0~.

###### Comparison between the Correlation Coefficient for Each Line in [Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}c, [3](#fig3){ref-type="fig"}c, and [4](#fig4){ref-type="fig"}c and the Corresponding Critical Value Based on 95% Confidence Interval

  solute            number of solvents (-)   degree of freedom (-)[a](#t5fn1){ref-type="table-fn"}   critical value (-)   *R*^2^ (-)
  ----------------- ------------------------ ------------------------------------------------------- -------------------- ------------
  isonicotinamide   4                        2                                                       0.950                0.957
  lovastatin        5                        3                                                       0.878                0.986
  phenacetin        3                        1                                                       0.997                0.997

Degree of freedom = number of solvents -- 2.

Conclusions {#sec4}
===========

According to CNT, is proposed in this work. [Equation [10](#eq10){ref-type="disp-formula"}](#eq10){ref-type="disp-formula"} is derived to investigate the nucleation kinetics in various solvents using the induction time data for isonicotinamide, lovastatin, and phenacetin. Although no clear relationship is observed between *A*~J~ and γ^1/2^ among various solvents for each system, *A*~0~ increases linearly with increasing γ^1/2^ among various solvents for each system, which is consistent with [eq [6](#eq6){ref-type="disp-formula"}](#eq6){ref-type="disp-formula"} derived based on CNT. Based on the analyzed results of nucleation kinetics in these systems, it is proposed that *A*~J~ consists of two parts: the first part *T*/η is proportional to *D*~AB~, and the other part *A*~0~ is proportional to γ^1/2^. Although *A*~J~ is dependent on *D*~AB~ among various solvents, *A*~0~ is not related to the dependence of *D*~AB~ on *T*/η(*T*,*S*) among various solvents. It is speculated that both γ and *A*~0~ are proportional to the solute--solvent interaction for the corresponding solvent.

Experimental Section {#sec5}
====================

The experimental apparatus consists of a 250 mL crystallizer immersed in a programmable thermostatic water bath shown in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}. The crystallizer is equipped with a magnetic stirrer at a constant stirring rate 350 rpm. The turbidity probe (Crystal Eyes manufactured by HEL limited) is used to detect the nucleation event during the induction time study.

![Schematic diagram of the experimental apparatus: (1) 250 mL crystallizer, (2) magnetic stirrer, (3) constant temperature water bath, (4) turbidity probe, (5) temperature probe, and (6) computer.](ao9b02102_0005){#fig5}

The induction times for three crystallization systems, including isonicotinamide (Alfa Aesar, purity 99%), lovastatin (Acros, purity 98%), and phenacetin (Acros, purity 78%) are measured in this work. Analytical grade solvents (purity 99.9%) are used to prepare the supersaturated solution. In each experiment, a 200 mL solution with the desired supersaturation is loaded into the crystallizer. The solution is held at 3 °C above the saturated temperature for 5--10 min to ensure a complete dissolution at the beginning of the experiment, which is also confirmed by the turbidity measurement. Then, the supersaturated solution is rapidly cooled to the desired temperature for the induction time measurements.
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*A*~J~

:   pre-exponential nucleation factor (m^--3^ s^--1^)

*A*~0~

:   intrinsic nucleation factor (Pa m^--3^ K^--1^)

*C*~0~

:   initial concentration of solute molecules (m^--3^)

*C*~eq~

:   equilibrium concentration of solute molecules (m^--3^)

*D*~AB~

:   solute diffusivity (m^2^/s)

*f*~*N*~

:   minimum detectable number density of accumulated crystals (m^--3^)

*f*~V~

:   minimum detectable volume fraction of accumulated crystals (-)

*J*

:   nucleation rate (m^--3^ s^--1^)

*k*~B~

:   Boltzmann constant (=1.38 × 10^--23^ J/K)

*k*~V~

:   volume shape factor (-)

*M*~W~

:   molar mass (kg/mol)

*N*~A~

:   Avogadro number (=6.02 × 10^23^ mol^--1^)

*r*~0~

:   molecular radius of solute (m)

*S*

:   supersaturation ratio (-)

*T*

:   temperature (K)

*t*

:   time (s)

*t*~i~

:   induction time (s)

*v*~m~

:   volume of the solute molecule (m^3^)
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γ

:   interfacial energy (J/m^2^)

ρ~C~

:   crystal density (kg/m^3^)

η

:   solution viscosity (Pa s)
